Third-Line Treatment Options for Kidney Cancer. [electronic resource]
Producer: 20170606Description: 813-5 p. digitalISSN:- 0890-9091
- Antineoplastic Agents -- adverse effects
- Biomarkers, Tumor -- genetics
- Carcinoma, Renal Cell -- drug therapy
- Cost-Benefit Analysis
- Drug Costs
- Drug Substitution
- Genetic Predisposition to Disease
- Genetic Testing -- methods
- Humans
- Kidney Neoplasms -- drug therapy
- Patient Selection
- Phenotype
- Precision Medicine
- Predictive Value of Tests
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.